Variant GADL1 and response to lithium in bipolar I disorder

New England Journal of Medicine

Volumn 370, Issue 19, 2014, Pages 1859-

  Anghelescu, Ion ^a   Dettling, Michael ^b  

^a Clinic Dr Fontheim   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; CARBOXYLYASE; TRANQUILIZER;

BIPOLAR I DISORDER; DRUG EFFICACY; GADL1 GENE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; LETTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT REFUSAL; BIPOLAR DISORDER; FEMALE; GENETICS; MALE; NOTE;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBOXY-LYASES; FEMALE; HUMANS; LITHIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899863681     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1401817     Document Type: Letter

References (1)

1. Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003;108:4-14. (Pubitemid 36783275)